FdaApplication
NDA 214900
Identifiers
- fda_app_no: NDA214900
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE LLC |
| application_type | NDA |
| approval_date | 2021-06-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BREXAFEMME | IBREXAFUNGERP CITRATE | EQ 150MG BASE | TABLET;ORAL |
1 product